Join
Live feed
·
INSIDERFilingvia Quantisnow
Akoya BioSciences Inc. logo

Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 3,850 shares, decreasing direct ownership by 2% to 206,408 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKYA· Akoya BioSciences Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKYA (Akoya BioSciences Inc.) and more on Quantisnow.